ILLUMINA, INC.

CA

Illumina is a biotechnology company

Active 2012–2026. The register lists this client once for every firm that files on its behalf; all 15 of its records are shown together here.

Filings
215
Filed By
15
Reported In-House
$15,960,000
Reported By Firms
$15,650,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2026 ILLUMINA, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$240,000
2026 AVENUE SOLUTIONS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 MILLER STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 AKIN GUMP STRAUSS HAUER & FELD 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$40,000
2026 THORN RUN PARTNERS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$30,000
2026 TODD STRATEGY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 AKIN GUMP STRAUSS HAUER & FELD 3rd Quarter (July 1 - Sep 30)
AMENDED
—
2026 JEFFREY J. KIMBELL & ASSOCIATES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$18,750
2026 ILLUMINA, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$300,000
2026 TODD STRATEGY GROUP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$80,000
Page 1 of 22  ·  215 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings